CINP (The International College of Neuropsychopharmacology) is a renowned international organization that was established over 60 years ago in Zurich, Switzerland. With a global presence and a strong support base from active members worldwide, CINP focuses on promoting research and education in the field of neuropsychopharmacology.

Through various events such as Training, Educational Programs, International Meetings, and World Congresses, CINP facilitates the dissemination of the latest research advances and new treatments for both clinicians and researchers. It aims to bridge the gap between clinical needs and research findings in order to improve patient care.

CINP's mission is to encourage and promote international scientific study, teaching, and the application of neuropsychopharmacology. It also strives to train psychiatrists in quantitative rating scales and research methodology, maintain partnerships with the pharmaceutical industry, and foster critical thinking on the limits and ethical issues in psychopharmacology research.

The organization's membership is diverse and includes psychiatrists, pharmacologists, basic scientists, and research psychologists. Its Executive Committee and Council, consisting of experts nominated by members from around the world, ensure effective leadership and knowledge in the field.

To stay connected and advance its objectives, CINP relies on dedicated committees that undertake various activities like bringing neuropsychopharmacology to developing regions and implementing mentor-mentee programs. Membership application is open to individuals, with a dedicated committee regularly reviewing applications.

Overall, CINP plays a crucial role in advancing research, education, and collaboration in neuropsychopharmacology on a global scale.